Modification of hexobarbitone sodium-induced hynosis in mice by beta adrenergic receptor blocking agents.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000526:Alprenolol / Q000494:pharmacology; D000818:Animals; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D005260:Female; D006591:Hexobarbital / Q000494:pharmacology*; D008297:Male; D008729:Methoxamine / Q000494:pharmacology; D051379:Mice; D011433:Propranolol / Q000494:pharmacology; D012890:Sleep / Q000187:drug effects*
D000319:Adrenergic beta-Antagonists; D000526:Alprenolol; D011433:Propranolol; D006591:Hexobarbital; D008729:Methoxamine